Improving gestational diabetes care: Mobile glucose monitoring to reduce complications.

Autor: Leyris Z; Gynecology and Obstetrics Department, Limoges University Hospital Center, Limoges, France., Bidan L; Gynecology and Obstetrics Department, Limoges University Hospital Center, Limoges, France., Puel Q; Pharmacology Department, Limoges University Hospital Center, Limoges, France., Galinat S; Endocrinology and Diabetology Department, Limoges University Hospital Center, Limoges, France., Aubard Y; Gynecology and Obstetrics Department, Limoges University Hospital Center, Limoges, France., Tordjman A; Gynecology and Obstetrics Department, Limoges University Hospital Center, Limoges, France., Galinat T; Endocrinology and Diabetology Department, Limoges University Hospital Center, Limoges, France., Teissier MP; Endocrinology and Diabetology Department, Limoges University Hospital Center, Limoges, France; Inserm U1094, IRD U270, University Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France., Salle L; Endocrinology and Diabetology Department, Limoges University Hospital Center, Limoges, France; Inserm U1094, IRD U270, University Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France. Electronic address: laurence.salle@unilim.fr.
Jazyk: angličtina
Zdroj: Annales d'endocrinologie [Ann Endocrinol (Paris)] 2024 Dec; Vol. 85 (6), pp. 569-573. Date of Electronic Publication: 2024 Jul 17.
DOI: 10.1016/j.ando.2024.07.003
Abstrakt: Background: Gestational diabetes mellitus (GDM) incurs risks for both mother and baby and requires close medical attention throughout pregnancy. This retrospective study examined the impact of myDiabby® software on GDM care and complications.
Material and Methods: The study population was divided between a pre-MyDiabby® group, with traditional monitoring before September 2017, and a myDiabby® group, using the myDiabby® app after September 2017. The aim was to compare the main complications of GDM and blood glucose control between the two groups, using Fisher's exact test or bilateral Student t-test as appropriate. Backward logistic regression was used to identify independent factors associated with glycemic control and caesarean section (C-section).
Results: There were 622 pre-myDiabby® and 649 myDiabby® patients. The myDiabby® group showed significantly lower risk of C-section (17.2% vs. 11.3%, P=0.004). After adjustment for pre-pregnancy body mass index (BMI), maternal age, prematurity, macrosomia and eclampsia, telemedicine was independently associated with a lower rate of C-section (OR=0.67, 95% CI: 0.51-0.89, P=0.005). Glycemic control improved (66.6% vs. 85.4%, P<0.001), with only a trend for need of insulin treatment. MyDiabby® remained associated with glycemic control (OR=3.15, 95% CI: 2.87-4.33, P<0.001) independently of pre-pregnancy BMI, insulin treatment or personal history of GDM.
Conclusion: These findings highlight the potential benefits of using telemedicine tools in the management of GDM during pregnancy.
(Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: